Accuracy in Diagnosis of Celiac Disease Without Biopsies in Clinical Practice.
暂无分享,去创建一个
Andreas Vécsei | Søren Thue Lillevang | Alexandra Papadopoulou | Alina Popp | Judit Gyimesi | M. Mearin | A. Thomas | I. Korponay-Szabó | K. Kurppa | M. Mäki | G. Castillejo | C. Ribes-Koninckx | R. Troncone | S. Husby | M. Van Winckel | R. Shamir | A. Vécsei | V. Villanacci | S. Koletzko | K. Werkstetter | S. Lillevang | G. Heilig | R. Nenna | E. Donat | F. Smets | A. Popp | R. Auricchio | J. Gyimesi | S. Buderus | Mehri Najafi | Riccardo Troncone | Ester Donat | Carmen Ribes-Koninckx | Kalle Kurppa | Markku Mäki | Alexandra Papadopoulou | J. Dolinsek | Stine Dydensborg Sander | M. Salemme | B. Filipiak | Raanan Shamir | Adrian G. Thomas | Vincenzo Villanacci | Sibylle Koletzko | Gemma Castillejo | Steffen Husby | Renata Auricchio | Françoise Smets | Katharina Julia Werkstetter | Ilma Rita Korponay-Szabó | Marianna Salemme | Gabriele Heilig | Maria Luisa Mearin | Adrian Thomas | Birgit Filipiak | Jernej Dolinšek | Stine Dydensborg Sander | Peter Szitanyi | Rafaella Nenna | Philippe Alliet | Francesca Penagini | Hélène Garnier-Lengliné | Almuthe Christine Hauer | Susana Corujeira | Myriam van Winckel | Stefan Buderus | Sonny Chong | S. Corujeira | P. Szitányi | H. Garnier-Lengliné | S. Chong | F. Penagini | M. Najafi | A. Hauer | P. Alliet
[1] C. Mitton,et al. Can Tissue Transglutaminase Antibody Titers Replace Small-Bowel Biopsy to Diagnose Celiac Disease in Select Pediatric Populations? , 2005, Pediatrics.
[2] A. Vestri,et al. Are ESPGHAN “Biopsy-Sparing” Guidelines for Celiac Disease also Suitable for Asymptomatic Patients? , 2015, The American Journal of Gastroenterology.
[3] E. Petrof,et al. Recurrent Clostridium difficile infection and the microbiome , 2015, Journal of Gastroenterology.
[4] Y. Elitsur,et al. Tissue Transglutaminase Levels Are Not Sufficient to Diagnose Celiac Disease in North American Practices Without Intestinal Biopsies , 2016, Digestive Diseases and Sciences.
[5] Marian Rewers,et al. Epidemiology of celiac disease: what are the prevalence, incidence, and progression of celiac disease? , 2005, Gastroenterology.
[6] A. Ivarsson,et al. Celiac Disease Can Be Predicted by High Levels of Anti-Tissue Transglutaminase Antibodies in Population-Based Screening , 2015, Journal of pediatric gastroenterology and nutrition.
[7] M N Marsh,et al. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue'). , 1992, Gastroenterology.
[8] C. Ribes-Koninckx,et al. Celiac Disease: The New Proposed ESPGHAN Diagnostic Criteria Do Work Well in a Selected Population , 2013, Journal of pediatric gastroenterology and nutrition.
[9] C. Isonne,et al. Weaknesses of histological analysis in celiac disease diagnosis: new possible scenarios , 2014, Scandinavian journal of gastroenterology.
[10] E. Bergseng,et al. Evidence that HLA-DQ9 confers risk to celiac disease by presence of DQ9-restricted gluten-specific T cells. , 2012, Human immunology.
[11] D. Sanders,et al. Quality not quantity for transglutaminase antibody 2: the performance of an endomysial and tissue transglutaminase test in screening coeliac disease remains stable over time , 2013, Clinical and experimental immunology.
[12] N. Caporaso,et al. The presence of anti‐endomysial antibodies and the level of anti‐tissue transglutaminases can be used to diagnose adult coeliac disease without duodenal biopsy , 2014, Alimentary pharmacology & therapeutics.
[13] G. Oberhuber,et al. The histopathology of coeliac disease: time for a standardized report scheme for pathologists. , 1999, European journal of gastroenterology & hepatology.
[14] L. Ronfani,et al. Accuracy of Diagnostic Antibody Tests for Coeliac Disease in Children: Summary of an Evidence Report , 2012, Journal of pediatric gastroenterology and nutrition.
[15] J. Hugot,et al. HLA-DQ relative risks for coeliac disease in European populations: a study of the European Genetics Cluster on Coeliac Disease. , 2004, Tissue antigens.
[16] D. Hasenclever,et al. Antibodies in the Diagnosis of Coeliac Disease: A Biopsy-Controlled, International, Multicentre Study of 376 Children with Coeliac Disease and 695 Controls , 2014, PloS one.
[17] M. Lyon,et al. Evaluation of the ESPGHAN Celiac Guidelines in a North American Pediatric Population , 2015, The American Journal of Gastroenterology.
[18] J. Ilonen,et al. Fate of Five Celiac Disease-Associated Antibodies During Normal Diet in Genetically At-Risk Children Observed from Birth in a Natural History Study , 2007, The American Journal of Gastroenterology.
[19] I. Korponay-Szabó,et al. Adaptive diagnosis of coeliac disease. , 2015, Best practice & research. Clinical gastroenterology.
[20] E. Levy,et al. Imbalances in Dietary Consumption of Fatty Acids, Vegetables, and Fruits Are Associated With Risk for Crohn's Disease in Children , 2007, The American Journal of Gastroenterology.
[21] L. Greco,et al. Diagnosis of celiac disease and applicability of ESPGHAN guidelines in Mediterranean countries: a real life prospective study , 2017, BMC Gastroenterology.
[22] Suzanne K. Lewis,et al. Variability in small bowel histopathology reporting between different pathology practice settings: impact on the diagnosis of coeliac disease , 2011, Journal of Clinical Pathology.
[23] K. Kaukinen,et al. Utility of the New ESPGHAN Criteria for the Diagnosis of Celiac Disease in At-risk Groups , 2012, Journal of pediatric gastroenterology and nutrition.
[24] R. Houwen,et al. A Biopsy Is Not Always Necessary to Diagnose Celiac Disease , 2011, Journal of pediatric gastroenterology and nutrition.
[25] A. Ivarsson,et al. Accuracy in Celiac Disease Diagnostics by Controlling the Small-bowel Biopsy Process , 2011, Journal of pediatric gastroenterology and nutrition.
[26] M. Hiele,et al. Defining thresholds of antibody levels improves diagnosis of celiac disease. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[27] R. Leis,et al. ESPGHAN 2012 Guidelines for Coeliac Disease Diagnosis: Validation Through a Retrospective Spanish Multicentric Study , 2016, Journal of pediatric gastroenterology and nutrition.
[28] William Egner,et al. ESPGHAN Guidance on Coeliac Disease 2012: Multiples of ULN for Decision Making Do Not Harmonise Assay Performance Across Centres , 2012, Journal of pediatric gastroenterology and nutrition.
[29] N. Lewis,et al. Systematic review: the use of serology to exclude or diagnose coeliac disease (a comparison of the endomysial and tissue transglutaminase antibody tests) , 2006, Alimentary pharmacology & therapeutics.
[30] R. Houwen,et al. Reproducibility of the histological diagnosis of celiac disease , 2011, Scandinavian journal of gastroenterology.
[31] K. Lynch,et al. Repeated Screening Can Be Restricted to At-Genetic-Risk Birth Cohorts , 2016, Journal of pediatric gastroenterology and nutrition.
[32] E. Bonifacio,et al. A Report on the International Transglutaminase Autoantibody Workshop for Celiac Disease , 2009, The American Journal of Gastroenterology.
[33] K. Giersiepen,et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition Guidelines for the Diagnosis of Coeliac Disease , 2012, Journal of pediatric gastroenterology and nutrition.
[34] M. Trnková,et al. Symptom positivity is essential for omitting biopsy in children with suspected celiac disease according to the new ESPGHAN guidelines , 2014, European Journal of Pediatrics.
[35] A. Florena,et al. Correlation Between IgA Tissue Transglutaminase Antibody Ratio and Histological Finding in Celiac Disease , 2012, Journal of pediatric gastroenterology and nutrition.
[36] M. Piqueras,et al. Are positive serum-IgA-tissue-transglutaminase antibodies enough to diagnose coeliac disease without a small bowel biopsy? Post-test probability of coeliac disease. , 2012, Journal of Crohn's & colitis.
[37] S. Guandalini,et al. Can we really skip the biopsy in diagnosing symptomatic children with celiac disease. , 2013, Journal of pediatric gastroenterology and nutrition.
[38] A. Tiberti,et al. Identification of a serum transglutaminase threshold value for the noninvasive diagnosis of symptomatic adult celiac disease patients: a retrospective study , 2016, Journal of Gastroenterology.
[39] G. Maltoni,et al. Prevalence of Celiac Disease in Children With Type 1 Diabetes Mellitus Increased in the Mid-1990s: An 18-year Longitudinal Study Based on Anti-endomysial Antibodies , 2008, Journal of pediatric gastroenterology and nutrition.
[40] W. Egner,et al. High‐titre circulating tissue transglutaminase‐2 antibodies predict small bowel villous atrophy, but decision cut‐off limits must be locally validated , 2014, Clinical and experimental immunology.